We are live on ! Find out more
TCM

Tekla Capital Management Portfolio holdings

AUM $2.56B
1-Year Est. Return 18.15%
This Fund
S&P 500
This Quarter Est. Return
+3.64%
1 Year Est. Return
+18.15%
3 Year Est. Return
+62.51%
5 Year Est. Return
+140.53%
10 Year Est. Return
+502.91%
AUM
$2.91B
AUM Growth
+$61.2M
Cap. Flow
+$64.4M
Cap. Flow %
2.22%
Top 10 Hldgs %
30.43%
Holding
226
New
26
Increased
31
Reduced
48
Closed
30

Top Buys

Rank Stock Value
1
ELV icon
Elevance Health
ELV
+$41M
2
ABT icon
Abbott
ABT
+$37M
3
MRNA icon
Moderna
MRNA
+$32.5M
4
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
+$29.2M
5
GILD icon
Gilead Sciences
GILD
+$26.5M

Top Sells

Rank Stock Value
1
ALXN
Alexion Pharmaceuticals
ALXN
+$60.5M
2
BDX icon
Becton Dickinson
BDX
+$22.1M
3
HUM icon
Humana
HUM
+$18.1M
4
TECH icon
Bio-Techne
TECH
+$16.1M
5
NVCR icon
NovoCure
NVCR
+$15.2M

Sector Composition

Rank Sector Weight
1 Healthcare 95.75%
2 Real Estate 2.99%
3 Industrials 0.1%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$163B
$117M 4.04%
1,815,906
+410,535
+29% +$26.5M
AMGN icon
2
Amgen
AMGN
$209B
$104M 3.57%
416,560
– –
JNJ icon
3
Johnson & Johnson
JNJ
$617B
$99.4M 3.42%
604,864
+58,059
+11% +$9.39M
ILMN icon
4
Illumina
ILMN
$31B
$94.8M 3.26%
253,703
-11,000
-4% -$4.49M
ABT icon
5
Abbott
ABT
$183B
$89.1M 3.07%
743,657
+312,512
+72% +$37M
VRTX icon
6
Vertex Pharmaceuticals
VRTX
$122B
$84.9M 2.92%
395,288
+89,978
+29% +$19.8M
UNH icon
7
UnitedHealth
UNH
$383B
$79M 2.72%
212,285
-6,900
-3% -$2.39M
HZNP
8
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$74.6M 2.57%
810,932
+345,916
+74% +$29.2M
REGN icon
9
Regeneron Pharmaceuticals
REGN
$77.4B
$72.6M 2.5%
153,505
-25,880
-14% -$12.6M
BIIB icon
10
Biogen
BIIB
$30.7B
$69.1M 2.38%
246,844
– –
ABBV icon
11
AbbVie
ABBV
$455B
$67.1M 2.31%
619,759
– –
MRNA icon
12
Moderna
MRNA
$23B
$61.8M 2.13%
472,302
+224,110
+90% +$32.5M
ELV icon
13
Elevance Health
ELV
$81.6B
$59.1M 2.03%
164,777
+127,644
+344% +$41M
MDT icon
14
Medtronic
MDT
$110B
$58.1M 2%
492,214
-42,700
-8% -$5M
BMY icon
15
Bristol-Myers Squibb
BMY
$132B
$56.3M 1.94%
892,453
-97,455
-10% -$6.06M
LLY icon
16
Eli Lilly
LLY
$1.03T
$54.6M 1.88%
292,114
+54,577
+23% +$10.7M
TMO icon
17
Thermo Fisher Scientific
TMO
$214B
$51.9M 1.78%
113,653
-13,900
-11% -$6.63M
CI icon
18
Cigna
CI
$76.1B
$45.9M 1.58%
189,921
+54,209
+40% +$12.1M
DHR icon
19
Danaher
DHR
$138B
$43M 1.48%
215,719
-32,261
-13% -$6.55M
MRK icon
20
Merck
MRK
$321B
$41.8M 1.44%
567,705
-20,121
-3% -$1.48M
SYK icon
21
Stryker
SYK
$133B
$37M 1.27%
151,830
-1,500
-1% -$360K
ZBH icon
22
Zimmer Biomet
ZBH
$18.4B
$33.3M 1.14%
214,048
-6,386
-3% -$989K
SGEN
23
DELISTED
Seagen Inc. Common Stock
SGEN
$31.3M 1.08%
225,490
-68,129
-23% -$11M
WAT icon
24
Waters Corp
WAT
$37.3B
$29.2M 1%
102,710
-6,800
-6% -$1.86M
HCA icon
25
HCA Healthcare
HCA
$85.7B
$28.8M 0.99%
152,897
-22,200
-13% -$3.91M
1
2 3 4 5

Similar funds

EST
EA Series Trust Havertown, Pennsylvania $2.84B AUM
VIA
Vident Investment Advisory Alpharetta, Georgia $2.9B AUM 24.67% 1-Year Est. Return
AWS
AJ Wealth Strategies New York $2.07B AUM 10.86% 1-Year Est. Return
JP
Jana Partners New York $1.34B AUM 4.95% 1-Year Est. Return
VCM
Vigilant Capital Management Portland, Maine $1.34B AUM 15.33% 1-Year Est. Return
FCFS
First Command Financial Services Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
FCB
First Command Bank Fort Worth, Texas $1.06B AUM 10.74% 1-Year Est. Return
BWM
BerganKDV Wealth Management Bloomington, Minnesota $1,000M AUM 9.95% 1-Year Est. Return

Tekla Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Tekla Capital Management held 226 positions worth $2.91B, up 2.1% from $2.85B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

Tekla Capital Management's Q1 2021 filing shows 26 new, 31 increased, 48 reduced and 30 closed positions. Its largest new stake was Universal Health Services: 71,323 shares worth $9.51M. The largest sale was Alexion Pharmaceuticals, an estimated $60.5M.

By sector, the portfolio is most concentrated in Healthcare at 96% of assets, up from 95% a quarter earlier, followed by Real Estate and Industrials.

  • Tekla Capital Management's largest Q1 2021 buy was Universal Health Services: 71,323 shares worth $9.51M.
  • Tekla Capital Management added most to Elevance Health in Q1 2021, an estimated $41M increase.
  • Tekla Capital Management's biggest Q1 2021 reduction was Alexion Pharmaceuticals, cutting an estimated $60.5M.
  • Tekla Capital Management fully exited NovoCure in Q1 2021, selling an estimated $15.2M.
  • Tekla Capital Management's ten largest holdings make up 30% of its $2.91B portfolio in Q1 2021.
  • Tekla Capital Management opened 26 new positions and closed 30 in Q1 2021.
  • Tekla Capital Management's portfolio value rose 2.1% quarter-over-quarter to $2.91B.

Based on Tekla Capital Management's 13F filing for Q1 2021, filed 14 May 2021.